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ABSTRACT: The preparation of osmium(II) complexes containing a CC6H4,CBzIm,CBzIm,CC6H4-tetradentate ligand with a –CH2CH2– 
link between the benzimidazolidene (BzIm) groups is described and the influence of the link on their structures and emissive prop-
erties is analyzed. The hexahydride complex OsH6(PiPr3)2 (1) reacts with 1,1’-diphenyl-3,3’-ethylenedibenzimidazolium bromide in 
dimethylformamide to afford OsBr{κ3-C,C,C-(C6H4-BzIm-CH2CH2-BzIm-Ph)}(CO)(PiPr3)2 (2), as a result of the direct metalation 
of both benzimidazolium moieties of the salt, the ortho-CH bond activation of a phenyl substituent, and the carbonylation of the 
metal center by action of the solvent. Treatment of 2 with Na[BH4] leads to the hydride derivative OsH{κ3-C,C,C-(C6H4-BzIm-
CH2CH2-BzIm-Ph)}(CO)(PiPr3)2 (3) which evolves into Os{κ4-C,C,C,C-(C6H4-BzIm-CH2CH2-BzIm-C6H4)}(CO)(PiPr3)2 (4) as a 
consequence of the assisted C-H bond activation of the second phenyl substituent. The use of dimethylsulfoxide instead of dime-
thylformamide allows the generation of the tetradentate ligand in one pot. Stirring of dimethylsulfoxide solutions of 1 leads to 
Os{κ4-C,C,C,C-(C6H4-BzIm-CH2CH2-BzIm-C6H4)}(DMSO)2 (5). The solvent molecules of 5 can be displaced by 1,2-
bis(diphenylphosphino)ethylene (bdppe), 1,2-bis(diphenylphosphino)benzene (dppbz) and tetrafluorobenzobarrelene (TFB) to yield 
the [4+2]-derivatives Os{κ4-C,C,C,C-(C6H4-BzIm-CH2CH2-BzIm-C6H4)}L2 (L2 = bdppe (6), dppbz (7), TFB (8)). The X-ray struc-
tures of 4, 6 and 7 reveal that in these compounds, the tetradentate ligand adopts a mer three-planar disposition of a phenyl and two 
benzimidazolidene groups with the other phenyl group situated in a perpendicular direction trans-disposed to L. The reason of this 
preference is electronic. Thus, the stereochemistry of 7 is the same as that found in the related complexes Os{κ2-C,C-(MeBzIm-
C6H4)}2(dppbz) (13) and Os{κ2-C,C-(MeBzIm*-C6H4)}2(dppbz) (14) containing two free orthometalated N-
phenylbenzimidazolidene ligands. Complexes 7, 13 and 14 are phosphorescent. The first of them shows emissions narrower and 
bluer than those of 13 and 14. 
INTRODUCTION  
Tetradentate ligands are less common than those with one, 
two, or three donor atoms. However, their marked abilities to 
enhance the stability of uncommon species make them a pow-
erful tool for designing novel types of transition metal com-
plexes with applications in catalysis,1 material science,2 biolo-
gy,3 or synthetic chemistry,4 among other fields. 
These ligands have been classified into three principal catego-
ries:5 i) macrocyclic, ii) acyclic of linear chain, and iii) acyclic 
of branched chain. Macrocyclic tetradentate ligands mainly 
coordinate in a plane, being porphyrins a phthalocyanines 
classical examples.6 Acyclic tetradentate ligands of linear 
chain afford complexes with stereochemistries which depend 
upon the rigidity of the ligand. More rigid ligands display 
planar7 or tetrahedral8 coordinations, whereas flexible mole-
cules and anions orientate their donor atoms to stabilize six-
coordinate geometrical isomers (I,9 II,10 and III11 in Chart 1). 
The chain of the acyclic tetradentate ligands of branched chain 
can be bifurcated at a donor atom,12 at an atom other than a 
donor atom,13 or a bridging group links two bidentate moie-
ties.14 The first type is the most common and best known 
among the ligands of this category, being tetraphosphines and 
tetraarsines classical molecules of this class.15 
 
Chart 1.  
Nitrogen, phosphorous, arsenic, oxygen and sulfur are typical 
donor atoms in tetradentate ligands.5 Carbon is much less 
common from a classical point of view. The ability of the N-
heterocyclic carbenes (NHCs) to tune the electron density of 
the metallic core of the complexes16 has given rise to the de-
sign of an increasing number of ligands based on these moie-
ties. Thus, in recent years, interesting families of complexes 
containing tetradentate ligands with one,17 two,18 three,19 and 
four NHC groups have been reported. Those with four NHC 
moieties form a novel group of neutral C,C,C,C-donor ligands. 
 The large majority of them are macrocyclic systems, which 
coordinate to generate a plane20 with some exceptions.21 A few 
acyclic systems have been also described. They can be de-
scribed as ligands of branched chain, with a rigid aromatic 
group linking two bidentate NHC units,22 and flexible systems 
of linear chain displaying both geometries I and II.23 
The chelate-assistance has been revealed as one of the most 
efficient ways to perform selective C-H bond activation reac-
tions.24 Among the used C-donor assistant groups, NHCs 
occupy a prominent place. As a consequence, NHC-assisted 
ortho-CH bond activation is a highly attractive synthetic 
method for creating anionic CNHC-Caryl chelate ligands. If one 
links two of these groups with a flexible chain, through a 
NHC-nitrogen atom, one could generate flexible dianionic 
tetradentate Caryl,CNHC,CNHC,Caryl-donor ligands of linear chain. 
Previously, the union of two 1-phenyl-3-methylimidazolidene 
ligands, through one of the meta-phenyl atoms, with an oxy-
gen link has allowed the formation of an square-planar 
CNHC,Caryl,Caryl,CNHC-tetradentate platinum(II) complex, which 
has demonstrated high efficiency in both monomer and excim-
er emission.25 In addition, it is well stablished that polyhy-
drides of platinum group metals, in particular IrH5(PPh3)226 
and OsH6(PiPr3)2,27 promote the metalation of imidazolium 
and benzimidazolium cations, to afford normal and abnormal 
NHC-derivatives. These polyhydrides have also the ability of 
activating σ-bonds, including aromatic C-H bonds.28 Thus, 
complex OsH6(PiPr3)2 has proven to facilitate the direct meta-
lation of the benzimidazolium moiety of 1-phenyl-3-methyl-1-
H-benzimidazolium and the ortho-CH bond activation of the 
phenyl substituent, to afford osmium(II)-bis(dihydrogen) 
complexes containing an anionic Caryl-CNHC-chelate ligand 
(Scheme 1).27e With these precedents in mind, we decided to 
link the free nitrogen atom of two 1-phenyl-benzimidazole 
moieties with a flexible ethylidene chain and to explore reac-
tions of the d2-osmium-hexahydride with the resulting 1,1’-
diphenyl-3,3’-ethylenedibenzimidazolium dication, in order to 
prepare the first transition metal complexes containing a dian-
ionic Caryl,CNHC,CNHC,Caryl-tetradentate ligand. The bidentate 
character of the 1,1’-diphenyl-3,3’-
ethylenedibenzimidazolidene moiety group has been previous-
ly demonstrated by Herrmann, Kühn, and co-workers.29 
 
 
Scheme 1. Synthesis of Osmium(II)-bis(dihydrogen) Com-
plexes Containing an Anionic Caryl-CNHC-chelate Ligand. 
This paper reports the preparation of osmium complexes con-
taining a dianionic Caryl,CNHC,CNHC,Caryl-tetradentate ligand, via 
CNHC,CNHC,Caryl-pincer intermediates and in one pot. Further-
more, it demonstrates that the link between the CNHC,Caryl units 
does not determine the geometry of the resulting species, 
whereas seems to produce a narrowing of the emission band 
when the osmium complex is phosphorescent. 
 
RESULTS AND DISCUSSION  
Formation of an Osmium(II) Complex Containing a Car-
yl,CNHC,CNHC,Caryl-tetradentate Ligand via Caryl,CNHC,CNHC-
pincer Intermediates. The process starts from the d2-
hexahydride OsH6(PiPr3)2 (1) and 1,1’-diphenyl-3,3’-
ethylenedibenzimidazolium bromide and involves the direct 
metalation of both benzimidazolium units and the sequential 
ortho-CH bond activation of the phenyl substituents. The C-H 
cleavages are promoted by hydride ligands, in agreement with 
the ability of the osmium-hydride complexes, in particular 
1,27,30 to activate C-H bonds. Scheme 2 summarizes the em-
ployed reactions. 
Treatment of dimethylformamide solutions of 1 with 1.0 equiv 
of the dibenzimidazolium salt, under reflux, for 20 min affords 
the carbonyl derivative OsBr{κ3-C,C,C-(C6H4-BzIm-CH2CH2-
BzIm-Ph)}(CO)(PiPr3) (2), which was isolated as a green solid 
in 57% yield. In addition to the direct metalation of both ben-
zimidazolium moieties of the salt and the ortho-CH bond 
activation of a phenyl substituent, the formation of 2 involves 
the carbonylation of the metal center by action of the solvent. 
In this context, it should be mentioned that the use of dime-
thylformamide as source of carbon monoxide is well-known.31 
Complex 2 was characterized by X-ray diffraction analysis. 
Figure 1 shows a view of the molecule. The structure proves 
the generation of a pincer ligand and the carbonylation of the 
metal center. The coordination around the osmium atom can 
be described as a distorted octahedron with the phosphine 
ligand and the bromide anion mutually trans disposed (P-Os-
Br = 174.61(3)º). The perpendicular plane is formed by the 
pincer, which acts with CNHC-Os-Caryl angles of 167.47(14)º 
(C(16)-Os-C(1)) and 77.22(15)º (C(7)-Os-C(1)) and a CNHC-
Os-CNHC angle of 94.31(15)º (C(7)-Os-C(16)), and the carbon-
yl group trans disposed to one of the benzimidazolidene units 
(C(7)-Os-C(29) = 162.67(16)º). The Os-CNHC bond lengths of 
2.092(4) Å (Os-C(16)) and 2.101(4) Å (Os-C(7)) compare 
well with those reported of Os-NHC compounds with normal 
coordination of the NHC ligand,27,32 whereas the Os-Caryl dis-
tance of 2.116(4) Å (Os-C(1)) is in accordance with those 
found in other five-membered osmacycles resulting from 
chelate-assisted C-H bond activation reactions.33 As expected 
for the presence of the carbonyl ligand, the IR spectrum of the 
compound shows a ν(CO) band a 1911 cm-1. In the 13C{1H} 
NMR spectrum in dichloromethane-d2, at room temperature, 
the carbonyl ligand and the metalated carbon atoms of the 
pincer display at 192.2 (NHC), 191.7 (CO), 188.2 (NHC), and 
152.6 (Ph) ppm doublets with typical cis C-P coupling con-
stants, between 10 and 4 Hz. A singlet at 10.8 ppm in the 
31P{1H} NMR spectrum is also a characteristic feature of this 
compound. 
 Scheme 2. Formation of an Osmium(II) Complex Containing a Caryl,CNHC,CNHC,Caryl-tetradentate Ligand via Caryl,CNHC,CNHC-pincer 
Intermediates. 
 
 
Figure 1. ORTEP diagram of complex 2 (50% probability ellip-
soids). Hydrogen atoms are omitted for clarity. Selected bond 
lengths (Å) and angles (deg): Os-Br = 2.6289(4), Os-P = 
2.3447(10), Os-C(1) = 2.116(4), Os-C(7) = 2.101(4), Os-C(16) = 
2.092(4), Os-C(29) = 1.880(4); Br-Os-P = 174.61(3), C(1)-Os-
C(7) = 77.22(15), C(1)-Os-C(16) = 167.47(14), C(1)-Os-C(29) = 
88.17(16), C(7)-Os-C(29) = 162.67(16), C(16)-Os-C(29) = 
98.46(16), C(7)-Os-C(16) = 94.31(15). 
Complex 2 reacts with Na[BH4], at -16 ºC, to formally replace 
the bromide anion by a hydride ligand. At this temperature, in 
the presence of methanol, the addition of an excess of the 
tetrahydrideborate salt to toluene solutions of 2 selectively 
lead to the hydride 3a, which was isolated as a yellow solid in 
68% yield. The substitution is accompanied by a change in the 
disposition of the phosphine ligand, which moves from cis to 
both benzimidazolidene units to trans to one of them. The 
stereochemistry proposed for 3a in Scheme 1 is strongly sup-
ported by the 1H and 13C{1H} NMR spectra of this compound, 
in dichloromethane-d2, at room temperature. In agreement 
with the mutually cis disposition of the hydride and phosphine 
ligands, the 1H NMR spectrum contains at -8.31 ppm a doublet 
with a H-P coupling constant of 29.4 Hz. In the 13C{1H} NMR 
spectrum, the resonances corresponding to the carbonyl group 
and the phenyl metalated carbon atom appear at 198.2 and 
159.7 ppm as doublets with typical cis C-P coupling constants 
of 8.5 and 7.7 Hz, respectively, whereas those due to the meta-
lated carbon atoms of the benzimidazolidene units are ob-
served at 192.7 and 191.2 ppm also as doublets but with very 
different C-P coupling constants of 63.6 and 8.1 Hz, respec-
tively; being the first of them characteristic for a trans C-P 
disposition and the second one for a cis C-P arrangement. A 
singlet at 20.1 ppm in the 31P{1H} NMR spectrum and a ν(CO) 
band a 1874 cm-1 in the IR are also characteristic features of 
this compound. 
Complex 3a isomerizes in toluene:methanol (4:1), at room 
temperature, to afford 3b in quantitative yield, after 4 days. 
The isomerization involves a change in the relative positions 
of the carbonyl and phosphine ligands. This is strongly sup-
ported by the 1H and 13C{1H} NMR spectra of the white solid 
obtained from the isomerization reaction, in dichloromethane-
d2, at room temperature. According to the mutually trans-
disposition of the hydride and phosphine ligands, the 1H NMR 
spectrum shows the hydride resonance at -8.99 ppm as a dou-
blet with a typical trans H-P coupling constant of 52.0 Hz. On 
the other, in agreement with the cis-disposition of phosphine, 
carbonyl and pincer ligands, the signals due to the carbonyl 
group and the metalated carbon atoms of the pincer are ob-
served at 196.0 (CO), 195.9 (NHC), 190.8 (NHC), and 153.1 
(Ph) ppm as doublets with typical cis-C-P coupling constants 
of 5.0, 6.3, 6.2 and 7.6 Hz, respectively, in the 13C{1H} NMR 
spectrum. The 31P{1H} NMR spectrum shows a singlet at 9.9 
ppm, whereas the IR contains a ν(CO) band a 1889 cm-1. 
The formation of 3a and its isomerization into 3b merit some 
additional comment. One should note that the direct replace-
ment of the bromide anion of 2 by a hydride of the tetrahy-
drideborate salt should afford 3b in one step, without the in-
termediation of 3a. So, the direct substitution of bromide by 
hydride must be rejected as a reasonable proposal. On the 
other hand, it should be pointed out that 3a and 3b can be 
interconverted via the square-planar osmium(0) intermediate 
Os{κ2-C,C-(Ph-BzIm-CH2CH2-BzIm-Ph)}(CO)(PiPr3) (A). 
Although square-planar d8-osmium complexes are rare, they 
are known.32e,34 Thus, isomer 3a could be generated by means 
of a concerted cis-oxidative addition of one of the ortho-CH 
bonds of the phenyl substituent of the benzimidazolidene 
group disposed cis to the carbonyl ligand of A, along the 
NHC-Os-CO axis, with the phenyl group on the carbonyl 
ligand. On the other hand the formation of 3b should take 
place through an analogous process on the phenyl substituent 
of the benzymidazolidene group disposed cis to the phosphine 
ligand, along the NHC-Os-PiPr3 axis (Scheme 3).35 The small-
er size of the carbonyl group with regard to the phosphine can 
explain why the formation of 3a is kinetically favored. Ac-
cording to this, it appears to be reasonable to think that the 
first step of the reaction of 2 with Na[BH4] is the generation of 
A as a consequence of the reduction of the starting complex by 
direct addition of one hydride of the tetrahydridoborate salt to 
the metalated phenyl group of 2 and subsequent release of 
bromide. In agreement with this, we have 
  
Scheme 3. Interconversion between Complexes 3a and 3b. 
 
observed that the reaction of 2 with Na[BD4] at -16 ºC leads to 
a partially deuterated 3a containing 0.5 deuterium atoms at the 
hydride position. 
The hydride ligand of 3b promotes the cleavage of one of the 
ortho-CH bonds of the free phenyl substituent of the diben-
zimidazolidene moiety with an activation barrier significantly 
higher than that corresponding to the first ortho-CH bond 
cleavage, which could be associated to the saturated character 
of 3a and the need to dissociate a ligand, most probably PiPr3, 
to perform the C-H bond activation process. 
Stirring of toluene solutions of 3b, at 100 ºC, produces the 
release of a hydrogen molecule and the formation of complex 
Os{κ4-C,C,C,C-(C6H4-BzIm-CH2CH2-BzImC6H4)}(CO)(PiPr3) 
(4, in Scheme 2), containing a Caryl,CNHC,CNHC,Caryl-
tetradentate ligand. This compound was isolated as a white 
solid in 89 % yield, after 4 days, and characterized by X-ray 
diffraction analysis. The structure (Figure 2) proves the for-
mation of the tetradentate ligand, which coordinates in a type 
II mode (Chart 1) with the phosphine ligand trans to a ben-
zimidazolidene unit and the carbonyl group trans to an aryl 
moiety. Thus, the coordination polyhedron around the osmium 
atom can be described as a distorted octahedron with NHC-
Os-aryl, NHC-Os-PiPr3, and aryl-Os-CO angles of 155.3(3)º 
(C(16)-Os-C(1)), 172.0(2)º (C(7)-Os-P(1)) and 178.6(3)º 
(C(28)-Os-C(29)), respectively. The Os-NHC bond lengths of 
2.029(8) (Os-C(7)) and 2.011(8) (Os-C(16)) Å and the Os-aryl 
distances of 2.144(8) (Os-C(1)) and 2.159(8) (Os-C(28)) Å 
compare well with the related parameters in 2 and complexes 
containing CarylCMeBzIm-bidentate ligands.27e,36 The asymmetry 
of the structure is also evident in the 1H and 13C{1H} NMR 
spectra of this compound, in dichloromethane-d2, at room 
temperature, which show resonances for inequivalent 
CarylCBzIm moieties. Thus, the 13C{1H} NMR spectrum contains 
four signals due to the metalated carbon atoms of the tetraden-
tate ligand at 205.9 (NHC), 181.1 (NHC), 155.1 (Ph) and 
154.0 (Ph) ppm. They appear as doublets with values for the 
C-P coupling constants of 6.3, 74.1, 11.9, and 6.4 Hz, respec-
tively, which are consistent with the structure shown in Figure 
2. The CO-resonance is observed at 190.3 ppm, as a doublet 
with a C-P coupling constant of 10.8 Hz, whereas the IR 
shows the ν(CO) band at 1907 cm-1. The 31P{1H} NMR spec-
trum contains a singlet at 6.9 ppm. 
 
Figure 2. ORTEP diagram of complex 4 (50% probability 
ellipsoids). Hydrogen atoms are omitted for clarity. Selected 
bond lengths (Å) and angles (deg): Os-P(1) = 2.424(2), Os-
C(1) = 2.144(8), Os-C(7) = 2.029(8), Os-C(16) = 2.011(8), 
Os-C(28) = 2.159(8), Os-C(29) = 1.840(9); P(1)-Os-C(7) = 
172.0(2), C(1)-Os-C(16) = 155.3(3), C(1)-Os-C(28) = 86.9(3), 
C(1)-Os-C(29) = 94.0(3), C(7)-Os-C(16) = 86.9(3), C(16)-Os-
C(28) = 76.2(3), C(16)-Os-C(29) = 102.6(4), C(28)-Os-C(29) 
= 178.6(3). 
 
Generation of the Caryl,CNHC,CNHC,Caryl Ligand in One Pot. 
The choice of the solvent in the planning of the chemical 
reactions of transition metal complexes is a crucial issue be-
cause of the physical and chemical properties of the employed 
medium can determine the nature of the final product.37 This is 
now here better illustrated than in the case of the reactions 
involving imidazolium and benzimidazolium salts, which 
show a marked dependence of both solvents and anions.26,27 In 
agreement with this, we have now observed that the use of 
dimethylsulfoxide instead of dimethylformamide allows the 
generation in one pot of the CC6H4CBzIm(CH2CH2)CBzImCC6H4-
tetradentate ligand without carbonylating the metal center. 
Stirring dimethylsulfoxide solutions of 1 and 1,1’-diphenyl-
3,3’-ethylenedibenzimidazolium bromide at 140 ºC, for 5 
hours leads to the bis(solvento) complex Os{κ4-C,C,C,C-
(C6H4-BzIm-CH2CH2-BzIm-C6H4)}(DMSO)2 (5), containing 
the target ligand. This complex was isolated as a yellow solid 
in 73% yield, according to eq 1. Its 1H and 13C{1H} NMR 
spectra, in dichloromethane-d2, between 213 K and 298 K are 
consistent with a type I disposition of the tetradentate ligand 
 (Chart 1) with the mutually cis-disposed dimethylsulfoxide 
molecules lying trans to the benzimidazolidene moieties in a 
perpendicular plane to the aryl-Os-aryl direction. Thus, in 
contrast to 4, the 13C{1H} NMR spectrum of 5 shows two 
resonances for the metalated carbon atoms of the tetradentate 
ligand, at 196.2 (NHC) and 156.4 (Ph) ppm. 
 
The dimethylsulfoxide molecules of 5 can be displaced by 
bidentate ligands to afford [4+2]-osmium species. Treatment 
of tetrahydrofuran solutions of 5 with 1,2-
bis(diphenylphosphine)ethylene (bdppe), 1,2-
bis(diphenylphosphine)benzene (dppbz), and tetrafluoroben-
zobarrelene (TFB), for 60 h (bdppe and dppbz) or 24 h (TFB), 
at 100 ºC leads to Os{κ4-C,C,C,C-(C6H4-BzIm-CH2CH2-
BzIm-C6H4}(L2) (L2 = bdppe (6), dppbz (7), TFB (8)) contain-
ing a dianionic C,C’,C’,C-tetradentate ligand and a diphos-
phine (6 and 7) or diolefin (8) group. These compounds were 
isolated as yellow (6 and 7) or white (8) solids in 70-40% 
yield, according to Scheme 4. 
 
Scheme 4. Synthesis of [4+2]-Osmium Species. 
Complexes 6 and 7 were characterized by X-ray diffraction 
analysis. The structures have two molecules chemically equiv-
alent but crystallographically independent in the asymmetric 
unit. Figure 3 shows a view of one of the molecules of 6, 
whereas Figure 4 shows a view of one of the molecules of 7. 
Both structures reveal that, in addition to the substitution, a 
change in the coordination mode of the tetradentate ligand, 
which goes from type I in 5 to type II in 6 and 7, has taken 
place. The change in the relative disposition of the donor 
atoms of the tetradentate ligand suggests a dissociative mech-
anism for the ligand substitution process, involving five-
coordinate-osmium transitory species, which should result 
from the release of a dimethylsulfoxide molecule from 5. The 
coordination polyhedron around the metal center of each com-
plex can be described as a distorted octahedron with the phe-
nyl group of a CC6H4CBzIm moiety trans disposed to the benzim-
idazolidene group of the other one (C(1)-Os(1)-C(16) = 
157.92(15)º) and 161.35(14)º for 6 and 158.3(3)º and 158.0(3)º 
for 7) and the remaining metalated carbon atoms trans-
disposed to the phosphorous atoms of the diphosphine (C(24)-
Os(1)-P(2) = 169.84(10)º and 172.06(10)º for 6 and 167.9(2)º 
and 167.8(2)º for 7, and C(7)-Os(1)-P(1) = 169.79(11)º and 
169.48(10)º for 6 and 172.0(2)º and 171.7(2)º for 7). The Os-
aryl bond lengths of 2.138(4) and 2.132(4) Å (Os-C(1)) and 
2.122(4) and 2.121(4) Å (Os-C(24)) for 6 and 2.144(7) and 
2.155(7) Å (Os(1)-C(1)) and 2.121(7) and 2.123(7) Å (Os(1)-
C(24)) for 7, as well as the Os-NHC distances of 2.017(4) and 
2.018(4) Å (Os(1)-C(16)) and 2.031(4) and 2.026(4) Å (Os(1)-
C(7)) for 6 and 2.056(7) and 2.017(8) Å (Os(1)-C(16)) and 
2.042(7) and 2.040(7) Å (Os(1)-C(7)) for 7, compare well with 
those of 4. The 1H, 13C{1H} and 31P{1H} NMR spectra of these 
compounds are consistent with the structures shown in Figures 
3 and 4 and also support a change in the relative disposition of 
the donor atoms of the tetradentate ligand with regard to 5. 
Thus, in contrast to the latter, the 13C{1H} NMR spectra, in 
dichloromethane-d2, at room temperature contain four reso-
nances for the metalated carbon atoms of the tetradentate 
ligand at 209.7 (NHC), 186.2 (NHC), 157.3 (Ph), and 152.5 
(Ph) ppm for 6 and 210.9 (NHC), 187.4 (NHC), 158.1 (Ph), 
and 153.9 (Ph) ppm for 7. In the 31P{1H} NMR spectra, the 
inequivalent phosphorous atoms of the diphosphines display 
two doublets at 35.4 and 22.2 ppm for 6 and at 32.1 and 18.7 
ppm for 7 with P-P coupling constants of about 5 Hz. 
 
Figure 3. ORTEP diagram of complex 6 (50% probability ellip-
soids). Hydrogen atoms are omitted for clarity. Selected bond 
lengths (Å) and angles (deg): Os(1)-P(1) = 2.3599(14), 
2.3446(14), Os(1)-P(2) = 2.3166(12), 2.3261(13), Os(1)-C(1) = 
2.138(4), 2.132(4), Os(1)-C(7) = 2.031(4), 2.026(4), Os(1)-C(16) 
= 2.017(4), 2.018(4), Os(1)-C(24) = 2.122(4), 2.121(4); P(1)-
Os(1)-P(2) = 82.19(4), 82.40(5), P(1)-Os(1)-C(1) = 93.17(11), 
95.65(11), P(1)-Os(1)-C(7) = 169.79(11), 169.48(10), P(1)-Os(1)-
C(16) = 103.06(11), 97.41(11), P(2)-Os(1)-C(24) = 169.84(10), 
172.06(10), C(1)-Os(1)-C(7) = 77.49(15), 77.71(15), C(1)-Os(1)-
C(16) = 157.92(15), 161.35(14), C(1)-Os(1)-C(24) = 89.96(15), 
90.96(15), C(7)-Os(1)-C(16) = 87.04(15), 91.02(15), C(16)-
Os(1)-C(24) = 75.77(15), 75.55(15). 
  
Scheme 5. Synthesis of Osmium Complexes with two CC6H4CBzIm-bidentate Ligands. 
 
 
Figure 4. ORTEP diagram of complex 7 (50% probability ellip-
soids). Hydrogen atoms are omitted for clarity. Selected bond 
lengths (Å) and angles (deg): Os(1)-P(1) = 2.3407(19), 
2.3374(19), Os(1)-P(2) = 2.3219(19), 2.3266(19), Os(1)-C(1) = 
2.144(7), 2.155(7), Os(1)-C(7) = 2.042(7), 2.040(7), Os(1)-C(16) 
= 2.056(7), 2.017(8), Os(1)-C(24) = 2.121(7), 2.123(7); P(1)-
Os(1)-P(2) = 81.32(7), 81.53(7), P(1)-Os(1)-C(1) = 98.1(2), 
98.3(2), P(1)-Os(1)-C(7) = 172.0(2), 171.7(2), P(1)-Os(1)-C(16) = 
97.7(2), 97.7(2), P(2)-Os(1)-C(24) = 167.9(2), 167.8(2), C(1)-
Os(1)-C(7) = 76.9(3), 76.6(3), C(1)-Os(1)-C(16) = 158.3(3), 
158.0(3), C(1)-Os(1)-C(24) = 89.5(3), 90.6(3), C(7)-Os(1)-C(16) 
= 88.8(3), 89.0(3), C(16)-Os(1)-C(24) = 76.1(3), 74.9(3). 
The 1H and 13C{1H} NMR spectra of the tetrafluorobenzobar-
relene complex 8,38 in dichloromethane-d2, at room tempera-
ture also support a type II disposition of the donor atoms of 
the tetradentate ligand, showing inequivalent olefinic bonds 
and aryl and benzimidazolidene groups. In the 1H NMR spec-
trum, the inequivalent olefinic hydrogen atoms display four 
resonances at 3.08, 2.82, 2.14, and 1.83 ppm, whereas the 
13C{1H} NMR spectrum contains four signals for the coordi-
nated atoms of the diolefin at 50.3, 49.8, 36.2, and 32.1 ppm, 
in addition to the resonances due to the metalated carbon at-
oms of the tetradentate ligand at 196.0 (NHC), 188.4 (NHC), 
155.8 (Ph), and 152.0 (Ph) ppm. 
Complexes with two CC6H4CBzIm-Bidentate Ligands: Influ-
ence of the Link. In order to know the influence of the –
CH2CH2– link between the benzimidazolidene groups on the 
disposition of the donor atoms of the tetradentate ligand 
around the metal center, we decided to prepare analogous 
compounds to 7 containing two free phenyl-
benzimidazolidene groups. Scheme 5 summarizes the proce-
dure used. 
Addition of one equivalent of dppbz to dichloromethane solu-
tions of the tetra(solvento) complexes [Os{κ2-C,C-(MeL-
C6H4)}(CH3CN)4]OTf (L = BzIm (9), BzIm* (10)), recently 
reported by us,36 produces the replacement of two acetonitrile 
molecules by a bidentate ligand to afford after 12 h the di-
phosphine derivatives [Os{κ2-C,C-(MeL-
C6H4)}(dppbz)(CH3CN)2]OTf (L = BzIm (11), BzIm* (12)), 
which were isolated as green solids in high yield (90-80%). 
The formation of these synthetic intermediates was confirmed 
by means of an X-ray diffraction structure of 11. Figure 5 
shows a view of the cation. The coordination polyhedron 
around the osmium atom can be rationalized as a distorted 
octahedron with the acetonitrile molecules mutually trans-
disposed (N(3)-Os-N(4) = 176.12(14)º). The perpendicular 
plane is formed by the bidentate ligands, which act with C(1)-
Os-C(10) and P(1)-Os-P(2) bite angles of 76.85(16)º and 
82.03(4)º, respectively. The Os-NHC and Os-aryl bond 
lengths of 2.093(4) (Os-C(1)) and 2.124(4) (Os-C(10)) Å, 
respectively, compare well with those observed in 2, 4, 6, and 
7. The 1H, 13C{1H}, and 31P{1H} NMR spectra of 11 and 12, in 
dichloromethane-d2, at room temperature are consistent with 
the structure shown in Figure 5. In the 1H NMR spectra, the 
most noticeable feature is the presence of only one acetonitrile 
resonance at 1.6 ppm, in accordance with the equivalence of 
these ligands. In the 13C{1H} NMR spectra, they display two 
singlets at 116 (CN) and 4 (CH3) ppm, whereas the metalated 
carbon atoms of the orthometalated NHC ligand give rise at 
about 187 (NHC) and at 148 (aryl) ppm to double doublets 
with C-P coupling constants close to 90 and 4 Hz and of about 
71 and 6 Hz, respectively. The 31P{1H} NMR spectra show at 
about 32 and 24 ppm doublets with a P-P coupling constant of 
17 Hz. 
  
Figure 5. ORTEP diagram of the cation of complex 11 (50% 
probability ellipsoids). Hydrogen atoms are omitted for clarity. 
Selected bond lengths (Å) and angles (deg): Os-P(1) = 
2.3451(11), Os-P(2) = 2.3748(11), Os-N(3) = 2.032(4), Os-N(4) = 
2.010(4), Os-C(1) = 2.093(4), Os-C(10) = 2.124(4); P(1)-Os-P(2) 
= 82.03(4), P(1)-Os-C(1) = 169.93(12), P(1)-Os-C(10) = 
94.71(11), P(2)-Os-C(1) = 106.12(11), P(2)-Os-C(10) = 
175.83(11), C(1)-Os-C(10) = 76.85(16), N(3)-Os-N(4) = 
176.12(14). 
Treatment of the dimethylformamide solutions of 11 and 12 
with 1.0 equiv of 1-phenyl-3-methyl-1H-benzimidazolium 
iodide and 1.0 equiv of 1-phenyl-3-methyl-1H-5,6-dimethyl-
benzimidazolium iodide, respectively, and 10 equiv of Et3N, at 
110 ºC, for 3 days gives rise to the replacement of the coordi-
nated acetonitrile molecules by the respective orthometalated 
benzimidazolidene ligand, generating the target compounds 
Os{κ2-C,C-(MeL-C6H4)}2(dppbz) (L = BzIm (13), BzIm* 
(14)). These complexes were isolated as yellow solids with 
moderate yield from 60% (13) to 20% (14). Complex 13 was 
characterized by X-ray diffraction analysis. Its structure (Fig-
ure 6), which can be described as an octahedron similar to that 
of 7 with angles P-Os-NHC, P-Os-aryl, and NHC-Os-aryl of 
172.85(12)º (P(1)-Os-C(7)), 172.18(12)º (P(2)-Os-C(24)), and 
165.16(15)º (C(1)-Os-C(16)), respectively; demonstrates that 
the –CH2CH2– link between the benzimidazolidene groups of 
the tetradentate ligand does not determine the stereochemistry 
of 4 and 6-8, since the disposition of the donor atoms around 
the metal centers of 13 and 7 is the same; i.e., the stereoiso-
mers 4, 6-8, 13 and 14 are thermodynamically controlled and 
the reason of the observed disposition for the donor atoms is 
electronic in origin. However, the –CH2CH2– link appears to 
have a significant influence on some parameters of the octahe-
dral structures of the complexes containing the tetradentate 
ligand. In this context, it should be noted that the link ap-
proaches the benzimidazolidene groups, reducing the NHC-
Os-NHC angle. Thus, while this angle is 97.88(15)º (C(7)-Os-
C(16)) for 13, it decreases until 88.8(3)º and 89.0(3)º in 7. The 
approach of the benzimidazolidene groups has also a marked 
influence on the dihedral angle containing these groups, which 
goes from 88.12 in 13 to 65.60º and 62.12º in 7. In contrast to 
the NHC-Os-NHC angle, the aryl-Os-aryl angles are similar: 
88.29(15) (C(1)-Os-C(24)) in 13 and 89.5(3)º and 90.6(3)º in 
7. The Os-NHC bond lengths 2.051(4) (Os-C(7)) and 2.059(4) 
(Os-C(16)) Å, and Os-aryl distances, 2.137(4) (Os-C(1)) and 
2.127(4) (Os-C(24)) Å, in 13 are also similar to those in 7. The 
1H, 13C{1H}, and 31P{1H} NMR spectra of 13 and 14 at room 
temperature, are in full agreement with those of 7. The 
13C{1H} NMR spectra, in dichloromethane-d2, show two reso-
nances for the metalated carbon atoms of the inequivalent 
benzimidazolidene groups, between 200 and 193 ppm, and 
two signals for the metalated carbon atoms of the inequivalent 
aryl groups between 159 and 152 ppm. The 31P{1H} NMR 
spectra, in dimethylformamide, contain two doublets (2JP-P ≈ 5 
Hz) at 30 ppm and at about 25 ppm. 
 
Figure 6. ORTEP diagram of complex 13 (50% probability ellip-
soids). Hydrogen atoms are omitted for clarity. Selected bond 
lengths (Å) and angles (deg): Os-P(1) = 2.3161(10), Os-P(2) = 
2.3113(10), Os-C(1) = 2.137(4), Os-C(7) = 2.051(4), Os-C(16) = 
2.059(4), Os-C(24) = 2.127(4); P(1)-Os-P(2) = 83.59(4), P(1)-Os-
C(1) = 96.10(11), P(1)-Os-C(7) = 172.85(12), P(1)-Os-C(16) = 
89.15(11), P(2)-Os-C(24) = 172.18(12), C(1)-Os-C(7) = 
77.38(15), C(1)-Os-C(16) = 165.16(15), C(1)-Os-C(24) = 
88.29(15), C(7)-Os-C(16) = 97.88(15), C(16)-Os-C(24) = 
77.30(16). 
 
Influence of the Link on the Emissive Properties of 7. Be-
cause several types of osmium(II) complexes with multiden-
tate NHC ligands have shown to be emissive upon photoexci-
tation,27d,39 the photophysical properties of 2-8 were investi-
gated. However, only complex 7 proved to be emissive. Then, 
in order to analyze the influence of the –CH2CH2– link of the 
tetratentate ligand on its emission, the photophysical proper-
ties of 13 and 14, with two free phenylbenzimidazolidene 
groups, were studied as well. 
Absorption spectra of 2.0x10-4 M 2-methyltetrahydrofuran 
solutions of 7, 13, and 14 in the visible region are collected in 
Table 1. As expected, the spectra of the three compounds are 
very similar, showing an intense absorption centered at about 
330 nm and a less intense band centered at 404 nm. On the 
basis of time-dependent calculations in tetrahydrofuran, they 
were assigned to metal-to-ligand charge transfer transitions 
with a remarkable π-π* character. 
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Figure 7. Emission spectra in the solid state at 298 K (a) and in 2-MeTHF at 77 K (b) for complexes 7, 13 and 14. 
 
Table 1. UV/Vis Experimental Dataa for Complexes 7, 13 and 
14 and Corresponding Computed TD-DFT Gas Phase Vertical 
Excitation Energies for Derivatives 7 and 13. 
Complex Obsd λ (nm) (ε (104 
M-1 cm-1)) 
Calcd λ (nm)b 
7 336 (5.0), 404 (0.6) 338 (0.1163), 341 (0.0088), 
400 (0.0119) 
13 328 (5.4), 404 (0.4) 321 (0.1222), 401 (0.003), 
406 (0.0063) 
14 330 (5.5), 404 (0.4)  
a UV/Vis data were recorded at room temperature in 2-MeTHF 
with a concentration 2.0·10-4 M. b Values corresponding to the 
oscillator strength, f, are given in parentheses. 
 
Complexes 7, 13, and 14 are emissive upon photoexcitation in 
the solid state at room temperature and in 2-
methyltetrahydrofuran at 77 K,40 displaying bands centered 
between 630 and 549 nm. Figure 7 depicts the emission spec-
tra, whereas Table 2 collects lifetimes and quantum yields 
which lie in the range 0.24-4.85 μs and between 0.046 and 
0.052, respectively. The emissions can be attributed to π-π* 
HOMO (65% Os + 38% NHC) to LUMO (94% diphosphine) 
So-T1 metal-to-ligand (osmium-to-diphosphine) charge transfer 
transitions. In accordance with this, the computed emission 
wavelength for 7 and 13, which has been estimated by means 
of the difference in energy between the optimized triplet excit-
ed state and the singlet state with the same geometry as the 
optimized triplet excited state, 662 nm for both compounds, is 
in reasonable agreement with the experimental values. 
The comparison of the spectra of Figure 7 reveals that the 
emission of complex 7, containing two orthometalated N-
phenylbenzimidazolidene moieties linked by a –CH2CH2– 
group, is narrower than those of 13 and 14, containing two 
separated orthometalated N-phenylbenzimidazolidene ligands, 
and is slightly shifted towards the blue; i.e., the presence of the 
link between the benzimidazolidene moieties seems to give 
rise to a narrower and bluer emission. 
 
 
 
 
Table 2. Photophysical Properties of Complexes 7, 13 and 14 
in Solid State at 298 K and Degassed 2-MeTHF at 77 K. 
Complex media (T/K) 
λem (nm) τ (s) Φ a 
7 solid (298) 600 (λexc 435) 0.24 0.050 
2-MeTHF 
(77) 
549 (λexc 337) 4.85  
13 solid (298) 630 (exc 480) 0.17 0.046 
2-MeTHF 
(77) 
599 (exc 460) 1.66  
14 solid (298) 602 (exc 460) 0.37 0.052 
2-MeTHF 
(77) 
600 (exc 400) 1.22  
a Measurements in solid state by doping 5% sample in PMMA 
film. 
CONCLUDING REMARKS 
This study has revealed that transition metal polyhydride com-
plexes can promote the direct metalation of the benzimidazoli-
um unit and the carbon direct C-H bond activation of the phe-
nyl substituent of two N-phenylbenzimidazolium moieties 
linked through a flexible –CH2CH2– chain, which is bonded to 
the remaining nitrogen atoms. The multi C-H bond activation 
process affords compounds containing a Caryl,CNHC,CNHC,Caryl-
tetradentate ligand. As a proof of concept, we show that the 
reactions of the d2-hexahydride complex OsH6(PiPr3)2 with 
1,1’-diphenyl-3,3’-ethylenedibenzimidazolium bromide give 
rise to Os{κ4-C,C,C,C-(C6H4-BzIm-CH2CH2-BzIm-C6H4}L2 
derivatives via OsH{κ3-C,C,C-(C6H4-BzIm-CH2CH2-BzIm-
Ph}L2 pincer-intermediates or in one pot, depending upon the 
reaction conditions. 
The tetradentate ligand avoids a four-planar coordination, 
whereas it favors a mer three-planar disposition with the 
fourth donor atom situated in a perpendicular direction (II in 
Chart 1). The reason of this preference is electronic, since the 
observed disposition for the donor atoms is not determined by 
the presence of the link between the benzimidazolidene groups 
and is also the found one in complexes containing two free 
orthometalated N-phenylbenzimidazolidene ligands. The link 
has a modest influence on some parameters of the structures of 
the resulting complexes, such as the BzIm-M-BzIm bite angle 
and the dihedral angle between the planes containing the ben-
zimidazoline groups. Although only one of the reported com-
plexes containing the pincer ligand is emissive, the compari-
 son of its emission spectra with those of compound containing 
two free phenylbenzimidazolidene groups seems to suggest 
that the link favors narrower and bluer emissions. 
In conclusion, two procedures for the preparation of osmi-
um(II) complexes containing novel Caryl,CNHC,CNHC,Caryl-
tetradentate ligands with a –CH2CH2– link between the NHC 
groups have been discovered and the influence of the link on 
the structure of the complexes and their emissive properties 
has been analyzed. 
 
EXPERIMENTAL SECTION 
General Information. All reactions were carried out with rigorous 
exclusion of air using Schlenk-tube techniques. Solvents (except 
DMF, THF and 2-MeTHF that were dried and distilled under argon) 
were obtained oxygen- and water-free from an MBraun solvent puri-
fication apparatus. 1H, 31P{1H} and 13C{1H} NMR spectra were 
recorded on Bruker 300 ARX, Bruker Avance 300 MHz, Bruker 
Avance 400 MHz, and Bruker Avance 500 MHz instruments. Chemi-
cal shifts (expressed in parts per million) are referenced to residual 
solvent peaks (1H, 13C{1H}) or external 85% H3PO4 (31P{1H}), or 
external CFCl3 (19F). Coupling constants J are given in hertz. Attenu-
ated total reflection infrared spectra (ATR-IR) of solid samples were 
run on a Perkin-Elmer Spectrum 100 FT-IR spectrometer. C, H, and 
N analyses were carried out in a Perkin-Elmer 2400 CHNS/O analyz-
er. High-resolution electrospray mass spectra were acquired using a 
MicroTOF-Q hybrid quadrupole time-of-flight spectrometer (Bruker 
Daltonics, Bremen, Germany). OsH6(PiPr3)2 (1),41 1,1’-diphenyl-3,3’-
ethylenedibenzimidazolium dibromide,29 [Os{κ2-C,C-(MeL-
C6H4)}(CH3CN)4]OTf (L = BzIm (9), BzIm* (10)),36 
[PhMeBzImH]I,27e and [PhMeBzIm*H]I27e were prepared by pub-
lished methods. 
Photophysical Studies. All the manipulations of the organometal-
lic compounds were carried out in strict absence of oxygen and water. 
An Evolution 600 spectrophotometer was used to record UV-vis 
spectra. Steady-state photoluminescence spectra were obtained with a 
Jobin-Yvon Horiba Fluorolog FL-3-11 spectrofluorometer. An IBH 
5000F coaxial nanosecond flash lamp was used to measure the life-
times. Photoluminescent quantum yield data were measured on a 
Hamamatsu Quantaurus-QY Absolute PL quantum yield C11347-11 
spectrometer. 
Reaction of OsH6(PiPr3)2 (1) with 1,1’-diphenyl-3,3’-
ethylenedibenzimidazolium dibromide in dimethylformamide: 
Preparation of OsBr{κ3-C,C,C-(C6H4-BzIm-CH2CH2-BzIm-
Ph)}(CO)(PiPr3) (2). A solution of 1 (250 mg, 0.484 mmol) in dime-
thylformamide (5 mL) was treated with 1,1’-diphenyl-3,3’-
ethylenedibenzimidazolium dibromide (279 mg, 0.484 mmol). The 
resulting mixture was refluxed for 20 min, getting a dark brown 
solution. After cooling at room temperature the solvent was removed 
in vacuo, affording a brown residue. Dichloromethane (5 mL) was 
added and the resulting suspension was filtered, getting a brown 
solution that was evaporated to dryness. Addition of methanol (4 mL) 
afforded a green solid, which was washed with further portions of 
methanol (2 x 3 mL) and dried in vacuo. Yield: 240 mg (57 %). Anal. 
Calcd. for C38H42BrN4OOsP: C, 52.35; H, 4.86; N, 6.43. Found: C, 
52.05; H, 5.05; N, 6.12. HRMS (electrospray, m/z) calcd for 
C38H43BrN4OOsP [M+H]+: 873.1949; found: 873.2000. IR (cm-1): 
ν(CO) 1911 (s). 1H NMR (300 MHz, CD2Cl2, 298 K): δ 8.48 (br, 1H, 
CH Ph), 8.24 (d, 3JH-H = 7.2, 1H, CH Ph), 7.88 (m, 2H, CH BzIm), 
7.61 (m, 3H, Ph), 7.48 (m, 3H, CH Ph and BzIm), 7.39 (m, 2H, Ph), 
7.27 (t, 3JH-H = 7.5, 1H, BzIm), 7.15 (t, 3JH-H = 7.5, 1H, BzIm), 6.98 (t, 
3JH-H = 7.5, 1H, BzIm), 6.88 (t, 3JH-H = 7.5, 1H, BzIm), 6.75 (d, 3JH-H = 
7.5, 1H, BzIm), 5.27, 5.00, 4.96, 4.59 (all m, 1H each, -CH2-), 1.54 
(m, 3H, PCH(CH3)2), 0.90 (dd, 3JH-H = 6.9, 3JH-P = 13.2, 9H, 
PCH(CH3)2), 0.71 (dd, 3JH-H = 7.2, 3JH-P = 12.9, 9H, PCH(CH3)2). 
13C{1H} + HMBC+ HSQC NMR (75.42 MHz, CD2Cl2, 298 K): δ 
192.2 (d, 2JC-P = 9.2, NCN), 191.7 (d, 2JC-P = 4.4, CO), 188.2 (d, 2JC-P 
= 6.2, NCN), 152.6 (d, 2JC-P = 7.4, Os-C Ph), 150.4 (s, Cq), 140.9 (s, 
CH Ph), 140.0, 138.9, 136.9, 134.7, 132.9 (all s, Cq Ph and BzIm), 
132.6, 130.1, 129.8, 129.5, 129.0, 124.6, 124.1, 123.2, 123.1, 123.0, 
121.6, 113.1, 112.6, 111.7, 109.9, 108.6 (all s, CH Ph and BzIm), 
46.7, 45.2 (both s, -CH2-), 29.0 (d, 1JP-C = 29, PCH(CH3)2), 19.7, 19.4 
(both s, PCH(CH3)2). 31P{1H} NMR (121.4 MHz, CD2Cl2, 298 K): δ 
10.8 (s). 
Reaction of OsBr{κ3-C,C,C-(C6H4-BzIm-CH2CH2-BzIm-
Ph)}(CO)(PiPr3) (2) with Na[BH4]: Preparation of cis-H,P-
OsH{κ3-C,C,C-(C6H4-BzIm-CH2CH2-BzIm-Ph)}(CO)(PiPr3) (3a). 
A solution of 2 (180 mg, 0.206 mmol) in toluene (5 mL) was cooled 
to -16 ºC and treated with an excess of Na[BH4] (79 mg, 2.1 mmol). 
After addition of some drops of methanol, the resulting mixture was 
stirred for 10 min at -16ºC and dried in vacuo. Toluene (6 mL) was 
added and the resulting suspension was filtered, getting a yellow 
solution that was evaporated to dryness. After cooling at -78 ºC, 
addition of pentane (4 mL) afforded a light yellow solid that was 
washed with further portions of pentane (2 x 3 mL) and dried in 
vacuo. Yield: 111 mg (68 %). Anal. Calcd. for C38H43N4OOsP: C, 
57.56; H, 5.47; N, 7.07. Found: C, 57.32; H, 5.40; N, 7.09. HRMS 
(electrospray, m/z) calcd for C38H42N4OOsP [M-H]+: 793.2708; 
found: 793.2718. IR (cm-1): ν(Os-H) 1900 (m), ν(CO) 1874 (s). 1H 
NMR (500 MHz, CD2Cl2, 298 K): δ 8.08 (m, 1H, CH), 7.70 (d, JH-H = 
7.6, 1H, CH), 7.63 (d, JH-H = 7.1, 1H, CH), 7.49-7.28 (m, 6H, CH), 
7.27 (m, 1H, -CH2-), 7.19 (m, 2H, CH), 7.10 (t, JH-H = 7.6, 1H, CH), 
6.93 (m, 2H, CH), 6.78 (t, 3JH-H = 7.1, 1H, CH), 6.70 (d, 3JH-H = 7.6, 
1H, CH), 6.43 (m, 1H, CH), 4.82 (m, 3H, -CH2-), 1.80 (m, 3H, 
PCH(CH3)2), 0.99 (dd, 3JH-H = 7.1, 3JH-P = 12.5, 9H, PCH(CH3)2), 0.83 
(dd, 3JH-H = 7.1, 3JH-P = 12.5, 9H, PCH(CH3)2), -8.31 (d, 2JH-P = 29.4, 
1H, OsH). 13C{1H} + HMBC+ HSQC NMR (125.76 MHz, CD2Cl2, 
298 K): δ 198.2 (d, 2JC-P = 8.5, CO), 192.7 (s, 2JC-P = 63.6, NCN), 
191.2 (d, 2JC-P = 8.1, NCN), 159.7 (d, 2JC-P = 7.7, Os-C Ph), 149.1 (s, 
Cq), 144.8 (s, CH Ph), 138.8, 138.1, 137.8, 136.0, 133.0 (all s, Cq Ph 
and BzIm), 131.7, 129.6, 129.1, 128.6, 128.0, 123.5, 123.2 122.6, 
122.5, 122.1, 119.2, 112.1, 111.7, 110.4 109.3, 108.6 (all s, CH Ph 
and BzIm), 47.3, 44.7 (both s, -CH2-), 27.9 (d, 1JP-C = 23.1, 
PCH(CH3)2), 20.6, 19.6 (both s, PCH(CH3)2). 31P{1H} NMR (121.49 
MHz, CD2Cl2, 298 K): δ 20.1 (s). 
Isomerization of cis-H,P-OsH{κ3-C,C,C-(C6H4-BzIm-CH2CH2-
BzIm-Ph)}(CO)(PiPr3) (3a) to trans-H,P-OsH{κ3-C,C,C-(C6H4-
BzIm-CH2CH2-BzIm-Ph)}(CO)(PiPr3) (3b). 3a (50 mg, 0.063 
mmol) was dissolved in toluene/methanol (4 mL/1 mL), and the 
solution was periodically checked by 31P{1H} NMR, showing that fter 
3 days at room temperature the isomerization to 3b is complete. The 
solution was evaporated to dryness, and pentane (4 mL) was added to 
afford a light yellow solid that was washed with further portions of 
pentane (2 x 3 mL) and dried in vacuo. Yield: 47 mg (94 %). Anal. 
Calcd. for C38H43N4OOsP: C, 57.56; H, 5.47; N, 7.07. Found: C, 
57.42; H, 5.23; N, 7.18. HRMS (electrospray, m/z) calcd for 
C38H42N4OOsP [M-H]+: 793.2708; found: 793.2724. IR (cm-1): ν(CO) 
1889 (s). 1H NMR (500 MHz, CD2Cl2, 298 K): δ 8.18 (d, 3JH-H = 7.2, 
1H, CH), 7.91 (d, 3JH-H = 7.2, 1H, CH), 7.81 (d, 3JH-H = 7.2, 1H, CH), 
7.59-7.47 (m, 5H, CH), 7.39-7.29 (m, 4H, CH), 7.18 (t, 3JH-H = 7.2, 
1H, CH), 7.06 (t, 3JH-H = 7.5, 1H, CH), 6.94 (t, 3JH-H = 7.5, 1H, CH), 
6.80 (t, 3JH-H = 7.0, 1H, CH), 6.70 (t, 3JH-H = 7.5, 1H, CH), 5.50, 4.84, 
4.78, 4.59 (all m, 1H each, -CH2-), 2.27 (m, 3H, PCH(CH3)2), 0.92 
(dd, 3JH-H = 7.0, 3JH-P = 12.5, 9H, PCH(CH3)2), 0.70 (dd, 3JH-H = 7.0, 
3JH-P = 12.0, 9H, PCH(CH3)2), -8.99 (d, 2JH-P = 52.0, 1H, OsH). 
13C{1H} + HMBC+ HSQC NMR (125.76 MHz, CD2Cl2, 298 K): δ 
196.0 (d, 2JC-P = 5.0, CO), 195.9 (d, 2JC-P = 6.3, NCN), 190.8 (d, 2JC-P 
= 6.2, NCN), 153.1 (d, 2JC-P = 7.6, Os-C Ph), 149.1 (s, Cq), 141.4 (s, 
CH Ph), 141.2, 138.9, 137.5, 135.1, 133.1 (all s, Cq Ph and BzIm), 
132.1, 130.4, 130.0, 129.6, 129.1, 124.2, 123.5, 122.5, 122.4, 122.2, 
119.7, 112.2, 111.9, 110.5, 109.2, 107.8 (all s, CH Ph and BzIm), 
47.4, 44.7 (both s, -CH2-), 29.0 (d, 1JP-C = 17.6, PCH(CH3)2), 20.3, 
19.5 (both s, PCH(CH3)2). 31P{1H} NMR (121.49 MHz, CD2Cl2, 298 
K): δ 9.9 (s). 
Preparation of Os{κ4-C,C,C,C-(C6H4-BzIm-CH2CH2-BzIm-
C6H4)}(CO)(PiPr3) (4). A solution of 3b (200 mg, 0.252 mmol) in 
toluene (10 mL) was heated at 100 ºC for 4 days in a schlenk provided 
with a Teflon closure. After cooling at room temperature the solution 
was filtered and dried in vacuo. Addition of diethyl ether (4 mL) 
 afforded an off white solid, which was washed with further portions 
of diethyl ether (4 x 3 mL) and dried in vacuo. Yield: 177.5 mg (89 
%). Anal. Calcd. for C38H41N4OOsP: C, 57.70; H, 5.22; N, 7.08. 
Found: C, 57.44; H, 5.17; N, 6.88. HRMS (electrospray, m/z) calcd 
for C38H42N4OOsP [M+H]+: 793.2708; found: 793.2706. IR (cm-1): 
ν(CO) 1907 (s). 1H NMR (300 MHz, CD2Cl2, 298 K): δ 8.12 (dd, 3JH-
H = 7.6, 3JH-H = 1.6, 1H, CH), 8.05 (d, 3JH-H = 1.6, 1H, CH), 7.90 (m, 
2H, CH), 7.49 (m, 2H, CH), 7.28 (m, 4H, CH), 7.16 (m, 3H, CH), 
6.85 (m, 1H, CH), 6.47 (m, 2H, CH), 6.30 (ddd, 3JH-H = 15.6, 3JH-H = 
12.2, 1JH-H = 1.8, 1H, -CH2-), 4.90 (ddd, 3JH-H = 15.6, 3JH-H = 3.4, 1JH-H 
= 1.8, 1H, -CH2-), 4.57 (ddd, 3JH-H = 13.6, 3JH-H = 3.4, 1JH-H = 1.8, 1H, 
-CH2-), 4.07 (ddd, 3JH-H = 13.6, 3JH-H = 12.2, 1JH-H = 1.8, 1H, -CH2-), 
2.08 (m, 3H, PCH(CH3)2), 1.21 (dd, 3JH-H = 6.8, 3JH-P = 14.0, 9H, 
PCH(CH3)2), 0.88 (dd, 3JH-H = 7.2, 3JH-P = 11.2, 9H, PCH(CH3)2). 
13C{1H} + HMBC+ HSQC NMR (100.61 MHz, CD2Cl2, 298 K): δ 
205.9 (d, 2JC-P = 6.3, NCN), 190.3 (d, 2JC-P = 10.8, CO), 181.1 (d, 2JC-P 
= 74.1, NCN), 155.1 (d, 2JC-P = 11.9, Os-C Ph), 154.0 (d, 2JC-P = 6.4, 
Os-C Ph), 150.7 (d, 3JC-P = 2.5, Cq Ph), 150.6 (d, 3JC-P = 4.5, Cq Ph), 
145.2, 141.1 (both s, CH Ph), 138.2 (d, 4JC-P = 3.1, Cq BzIm), 136.6 (s, 
Cq BzIm), 135.8 (s, Cq BzIm), 132.4 (s, Cq BzIm), 125.0, 123.4, 123.1, 
122.8, 122.6, 122.4, 122.3, 121.7, 112.9, 111.6, 111.5, 111.3, 110.1, 
108.9 (all s, CH Ph and BzIm), 48.0, 44.9 (both s, -CH2-), 24.6 (d, 1JP-
C = 20.5, PCH(CH3)2), 22.2 (s, PCH(CH3)2), 18.8 (d, 2JP-C = 3.0, 
PCH(CH3)2). 31P{1H} NMR (161.98 MHz, CD2Cl2, 298 K): δ 6.9 (s). 
Reaction of OsH6(PiPr3)2 (1) with 1,1’-diphenyl-3,3’-
ethylenedibenzimidazolium dibromide in dimethylsulfoxide: 
Preparation of Os{κ4-C,C,C,C-(C6H4-BzIm-CH2CH2-BzIm-
C6H4)}(DMSO)2 (5). A solution of 1 (200 mg, 0.387 mmol) in dime-
thylsulfoxide (5 mL) was treated with 1,1’-diphenyl-3,3’-
ethylenedibenzimidazolium dibromide (223 mg, 0.387 mmol). The 
resulting mixture was stirred at 140 ºC for 5 h, getting a yellow solu-
tion. After cooling at room temperature the solvent was removed in 
vacuo, affording a yellow residue. Acetonitrile (7 mL) was added and 
the resulting suspension was filtered. The yellow solution thus ob-
tained was evaporated to dryness. Addition of diethyl ether (5 mL) 
caused the precipitation of a light yellow solid that was washed with 
further portions of diethyl ether (6 x 5 mL) and dried in vacuo. Yield: 
215 mg (73 %). Anal. Calcd. for C32H32N4O2OsS2: C, 50.64; H, 4.25; 
N, 7.38; S, 8.45. Found: C, 50.33; H, 4.45; N, 7.17; S, 8.21. HRMS 
(electrospray, m/z) calcd for C32H33N4O2OsS2 [M+H]+: 761.1651; 
found: 761.1737. IR (cm-1): ν(C=C) 1570 (w), ν(S=O) 1047 (vs). 1H 
NMR (300 MHz, CD2Cl2, 298 K): δ 8.46 (dd, 3JH-H = 6.3, 4JH-H = 2.1, 
2H, Ph), 8.14 (m, 2H, BzIm), 7.94 (dd, 3JH-H = 7.5, 4JH-H = 1.5, 2H, 
Ph), 7.52 (m, 2H, BzIm), 7.34 (m, 4H, BzIm), 7.27-7.18 (m, 4H, Ph), 
5.12-4.93 (m, 4H, -CH2-), 2.33 (s, 6H, (CH3)2S=O), 2.26 (s, 6H, 
(CH3)2S=O). 13C{1H} + HMBC+ HSQC NMR (75.4 MHz, CD2Cl2, 
298 K): δ 196.2 (s, NCN), 156.4 (s, Os-C Ph), 155.0 (s, Cq Ph), 141.8 
(s, CH Ph), 138.3, 133.7 (both s, Cq BzIm), 124.7, 123.5, 123.1, 
122.3, 113.0, 111.2, 109.4 (all s, CH Ph and BzIm), 46.9 (s, -CH2-), 
46.8, 46.6 (both s, (CH3)2S=O). 
Reaction of Os{κ4-C,C,C,C-(C6H4-BzIm-CH2CH2-BzIm-
C6H4)}(DMSO)2 (5) with cis-1,2-bis(diphenylphosphino)ethylene 
(bdppe): Preparation of Os{κ4-C,C,C,C-(C6H4-BzIm-CH2CH2-
BzIm-C6H4)}(bdppe) (6). In a schlenk flask provided with a teflon 
closure a solution of 5 (200 mg, 0.264 mmol) in THF (10 mL) was 
treated with bdppe (105 mg, 0.264 mmol). The resulting mixture was 
stirred at 100ºC for 60 h, getting a yellow solution. After cooling at 
room temperature the solvent was removed in vacuo. Dichloro-
methane (10 mL) was added and the resulting solution was filtered 
and evaporated to dryness. Addition of acetonitrile (5 mL) caused 
precipitation of a light yellow solid that was washed with further 
portions of acetonitrile (2 x 5 mL) and subsequently with diethyl ether 
(3 x 5 mL) and dried in vacuo. Yield: 108 mg (41 %). Anal. Calcd. for 
C54H42N4OsP2: C, 64.92; H, 4.24; N, 5.61. Found: C, 64.81; H, 4.08; 
N, 5.48. HRMS (electrospray, m/z) calcd for C54H43N4OsP2 [M+H]+: 
1001.2577; found: 1001.2537. IR (cm-1): ν(C=C) 1570 (w). 1H NMR 
(500 MHz, CD2Cl2, 298 K): δ 8.08-8.03 (m, 1H, CH), 7.75 (d, 3JH-H = 
7.5, 1H, CH), 7.65 (ddd, 2JH-P = 50.2, 3JH-H = 9.0, 3JH-P = 7.5, 1H, 
PCH=), 7.59 (m, 1H, CH), 7.51 (d, 3JH-H = 7.5, 1H, CH), 7.37-7.35 
(m, 1H, CH), 7.33-7.18 (m, 10H, CH and PCH=), 7.13 (dt, JH-H = 2.0, 
3JH-H = 8.0, 2H, CH), 7.09-6.90 (m, 11H, CH), 6.83 (dt, 4JH-H = 1.0, 
3JH-H = 7.5, 1H, CH), 6.75-6.72 (m, 1H, CH), 6.70 (dt, 4JH-H = 1.0, 3JH-
H = 7.0, 1H, CH), 6.50-6.44 (m, 1H, CH), 6.41 (dt, 4JH-H = 2.0, 3JH-H = 
8.0, 2H, CH), 6.35 (t, JH-H = 7.2, 1H, CH), 6.32-6.28 (m, 2H, CH), 
5.85-5.78 (m, 1H, -CH2-), 4.43-4.36 (m, 2H, -CH2-), 3.93-3.87 (m, 
1H, -CH2-). 13C{1H} + HMBC+ HSQC NMR (125.68 MHz, CD2Cl2, 
298 K): δ 209.7 (t, 2JC-P = 4.6, NCN), 186.2 (dd, 2JC-P = 8.4, 2JC-P = 
80.9, NCN), 157.3 (t, 2JC-P = 6.1, Os-C Ph), 152.5 (dd, 2JC-P = 13.1, 
2JC-P = 56.5, Os-C Ph), 152.2 (dd, 2JC-P = 30.3, 1JC-P = 41.5, P-CH=), 
151.8 (d, JC-P = 3.3, Cq), 148.9 (d, JC-P = 3.8, Cq), 145.0 (dd, 2JC-P = 
29.7, 1JC-P = 39.5, P-CH=), 142.7 (d, JC-P = 38.8, Cq), 141.8 (d, JC-P = 
9.9, CH), 141.7 (s, CH), 138.6 (d, JC-P = 3.5, Cq), 137.1 (d, JC-P = 29.9, 
Cq), 137.0, 136.6 (both s, Cq), 135.0 (t, JC-P = 2.1, CH), 134.6 (dd, JC-P 
= 5.6, JC-P = 34.9, Cq), 133.6 (d, JC-P = 2.9, Cq), 133.2, 133.1 (both s, 
CH), 132.6 (d, JC-P = 1.9, Cq), 131.9 (d, JC-P = 10.4, CH), 129.5 (d, JC-
P = 1.6, CH), 129.3 (d, JC-P = 9.3, CH), 128.6 (d, JC-P = 1.6, CH), 
128.4 (d, JC-P = 8.5, CH), 127.9, 127.8 (both s, CH), 127.6 (d, JC-P = 
8.0, CH), 126.9 (d, JC-P = 8.7, CH), 123.9, 123.6, 122.6, 122.1, 121.8, 
121.2, 120.6, 119.2, 111.8, 111.4, 111.0, 110.5, 109.8, 107.4 (all s, 
CH), 47.6 (s, -CH2-), 44.9 (d, 4JC-P = 3.5, -CH2-). 31P{1H} NMR 
(121.4 MHz, CD2Cl2, 298 K): δ 35.4 (d, 2JP-P = 3.8), 22.2 (d, 2JP-P = 
3.8). 
Reaction of Os{κ4-C,C,C,C-(C6H4-BzIm-CH2CH2-BzIm-
C6H4)}(DMSO)2 (5) with 1,2-bis(diphenylphosphino)benzene 
(dppbz): Preparation of Os{κ4-C,C,C,C-(C6H4-BzIm-CH2CH2-
BzIm-C6H4)}(dppbz) (7). In a schlenk flask provided with a teflon 
closure a solution of 5 (200 mg, 0.264 mmol) in THF (10 mL) was 
treated with dppbz (118 mg, 0.264 mmol). The resulting mixture was 
stirred at 100 ºC for 60 h, getting a yellow solution. After cooling at 
room temperature the solvent was removed in vacuo. Dichloro-
methane (10 mL) was added and the resulting solution was filtered 
and evaporated to dryness. Addition of acetonitrile (5 mL) caused 
precipitation of a yellow solid that was washed with further portions 
of acetonitrile (2 x 5 mL) and subsequently with diethyl ether (3 x 5 
mL) and dried in vacuo. Yield: 215 mg (68%). Anal. Calcd. for 
C58H44N4OsP2: C, 66.40; H, 4.23; N, 5.34. Found: C, 66.01; H, 4.00; 
N, 5.07. HRMS (electrospray, m/z) calcd for C58H45N4OsP2 [M+H]+: 
1051.2734; found: 1051.2695. IR (cm-1): ν(C=C) 1570 (w). 1H NMR 
(500 MHz, CD2Cl2, 298K): δ 8.00 (dd, 3JH-H = 7.0, 4JH-H = 1.5, 1H, 
CH), 7.63 (t, 3JH-H = 8.0, 2H, CH), 7.58 (m, 1H, CH), 7.53-7.50 (m, 
3H, CH), 7.38 (d, 3JH-H = 7.5, 1H, CH), 7.35 (d, 3JH-H = 7.5, 1H, CH), 
7.29-7.25 (m, 8H, CH), 7.16-7.14 (m, 3H, CH), 7.08-7.00 (m, 3H, 
CH), 6.95-6.88 (m, 6H, CH), 6.79-6.76 (m, 3H, CH), 6.73 (t, 3JH-H = 
7.5, 1H, CH), 6.63 (dt, 4JH-H = 1.0, 3JH-H = 7.2,1H, CH), 6.59 (dt, 4JH-H 
= 1.0, 3JH-H = 7.0,1H, CH), 6.39-6.35 (m, 3H, CH), 6.30 (t, 3JH-H = 
8.5, 2H, CH), 5.80-5.74 (m, 1H, -CH2-), 4.32-4.28 (m, 2H, -CH2-), 
3.86-3.80 (m, 1H, -CH2-). 13C{1H} + HMBC+ HSQC NMR (125.68 
MHz, CD2Cl2, 298K): δ 210.9 (t, 2JC-P = 4.3, NCN), 187.4 (dd, 2JC-P = 
7.9, 2JC-P = 79.7, NCN), 158.1 (t, 2JC-P = 6.4, Os-C Ph), 153.9 (dd, 2JC-
P = 12.5, 2 JC-P = 55.5, Os-C Ph), 151.7 (d, JC-P = 3.2, Cq), 149.4 (d, JC-
P = 3.8, Cq), 148.6 (dd, JC-P = 47.2, JC-P = 34.2, Cq), 144.9 (dd, JC-P = 
41.9, JC-P = 36.3, Cq), 143.7 (d, JC-P = 5.4, Cq), 143.5 (d, JC-P = 5.4, 
CH), 142.3 (s, CH), 138.3 (d, JC-P = 3.6, Cq), 137.2 (d, JC-P = 28.8, 
Cq), 137.0, 136.7 (both s, Cq),136.2 (d, JC-P = 9.7, CH), 133.8 (d, JC-P 
= 11.9, CH), 133.5 (d, JC-P = 3.3, Cq), 132.8 (d, JC-P = 14.8, CH), 
132.3 (d, JC-P = 1.9, Cq), 132.2 (d, JC-P = 10.3, CH), 131.9 (dd, JC-P = 
6.9, JC-P = 31.8, Cq), 131.7 (d, JC-P = 13.9, CH), 130.0 (d, JC-P = 9.3, 
CH), 129.6 (d, JC-P = 3.9, CH), 129.2, 129.0 (both s, CH), 128.9 (d, JC-
P = 3.6, CH), 128.3 (s, CH), 127.9 (d, JC-P = 9.0, CH), 127.5, 127.4 
(both s, CH), 127.2 (d, JC-P = 8.7, CH), 126.4 (d, JC-P = 8.4, CH), 
123.3, 122.7, 122.5, 122.0, 121.7, 121.1, 120.4, 119.3, 112.3, 111.2, 
111.1, 110.6, 109.7, 107.3 (all s, CH), 47.5 (s, -CH2-), 45.0 (d, 4JC-P = 
3.5, -CH2-). 31P{1H} NMR (121.4 MHz, CD2Cl2, 298K): δ 32.1 (d, 
2JP-P = 5.5), 18.7 (d, 2JP-P = 5.5). 
Reaction of Os{κ4-C,C,C,C-(C6H4-BzIm-CH2CH2-BzIm-
C6H4)}(DMSO)2 (5) with tetrafluorobenzobarrelene (TFB): Prep-
aration of Os{κ4-C,C,C,C-(C6H4-BzIm-CH2CH2-BzIm-
C6H4)}(TFB) (8). In a Schlenk flask provided with a teflon closure a 
solution of complex 5 (200 mg, 0.264 mmol) in THF (10 mL) was 
treated with TFB (108 mg, 0.474 mmol). The resulting mixture was 
stirred at 100 ºC for 24 h, getting a light brown solution. After cooling 
at room temperature the solvent was removed in vacuo. The brown 
 residue thus obtained was dissolved in toluene (5 mL), and the result-
ing solution was filtered through Celite. Removal of toluene and 
addition of methanol (5 mL) afforded a white solid that was washed 
with further portions of methanol (2 x 3 mL) and dried in vacuo. 
Yield: 94 mg (43 %). Anal. Calcd. for C40H26F4N4Os: C, 57.96; H, 
3.16; N, 6.76. Found: C, 58.23; H, 3.39; N, 6.51. HRMS (electros-
pray, m/z) calcd for C40H27F4N4Os [M+H]+: 831.1783; found: 
831.1765. IR (cm-1): ν(C=C) 1488 (s). 1H NMR (500 MHz, CD2Cl2, 
298 K): δ 8.85 (d, 3JH-H = 7.5, 1H, Ph), 8.19 (d, 3JH-H = 7.5, 1H, Ph), 
8.08 (d, 3JH-H = 7.5, 1H, Ph), 8.04 (dd, 3JH-H = 7.5, 4JH-H = 1.0, 1H, 
Ph), 7.83 (dd, 3JH-H = 7.5, 4JH-H = 1.0, 1H, Ph), 7.77 (d, 3JH-H = 7.5, 
1H, Ph), 7.76 (d, 3JH-H = 7.5, 1H, Ph), 7.59 (dt, 4JH-H = 1.0, 3JH-H = 7.5, 
1H, Ph), 7.52 (dt, 4JH-H = 1.0, 3JH-H = 7.5, 1H, Ph), 7.48 (dt, 4JH-H = 
1.0, 3JH-H = 7.5, 1H, Ph), 7.42 (dt, 4JH-H = 1.0, 3JH-H = 7.5, 1H, Ph), 
7.21 (dt, 4JH-H = 1.0, 3JH-H = 7.5, 1H, Ph), 7.14 (t, 3JH-H = 7.5, 1H, Ph), 
7.08 (d, 3JH-H = 7.5, 1H, Ph), 6.86 (dt, 4JH-H = 1.0, 3JH-H = 7.5, 1H, Ph), 
6.68 (dt, 4JH-H = 1.0, 3JH-H = 7.5, 1H, Ph), 6.18 (dd, 3JH-H = 14.0, 3JH-H 
= 12.0, 1H, -CH2-), 5.32 (dd, 3JH-H = 5.3, 3JH-H = 5.3, 1H, -CH TFB), 
5.22 (ddd, 3JH-H = 14.0, 3JH-H = 3.0, 2JH-H = 1.5, 1H, -CH2-), 4.85 (dd, 
3JH-H = 5.3, 3JH-H = 5.3, 1H, -CH TFB), 4.79 (dd, 3JH-H = 14.0, 3JH-H = 
3.0, 1H, -CH2-), 4.02 (ddd, 3JH-H = 14.0, 3JH-H = 12.0, 4JH-H = 1.5, 1H, 
-CH2-), 3.08 (dd, 3JH-H = 5.3, 3JH-H = 5.3, 1H, =CH TFB), 2.82 (dd, 
3JH-H = 5.3, 3JH-H = 5.3, 1H, =CH TFB), 2.14 (dd, 3JH-H = 5.3, 3JH-H = 
5.3, 1H, =CH TFB), 1.83 (dd, 3JH-H = 5.3, 3JH-H = 5.3, 1H, =CH 
TFB).13C{1H}+ HMBC+ HSQC NMR (125.68 MHz, CD2Cl2, 298 
K): δ 196.0 (s, NCN), 188.4 (s, NCN), 155.8 (s, Os-C Ph), 152.0 (s, 
Os-C Ph), 148.1, 147.1 (both s, C Ph), 143.1 (s, CH Ph), 140.4 (m, C-
F, TFB), 138.8 (s, C Ph), 138.5 (m, C-F, TFB), 137.9 (s, CH, Ph), 
131.8, 134.4, 136.8 (all s, C Ph and BzIm), 134.1, 133.7 (both m, C 
TFB), 125.4, 124.2, 123.6, 123.5, 123.1, 122.4, 122.2, 121.9, 113.4, 
112.4, 112.3, 111.3, 110.6, 108.6 (all s, CH Ph and BzIm), 50.3, 49.8 
(both s, =CH TFB), 48.4, 44.1 (both s, -CH2-), 39.4, 36.3 (both s, -CH 
TFB), 36.2, 32.1 (both s, =CH TFB). 19F{1H} NMR (282.34 MHz, 
CD2Cl2, 298 K): δ -149.2, -150.2, -163.3 (all m, C-F). 
Reaction of [Os{κ2-C,C-(MeBzIm-C6H4)}(NCCH3)4]OTf (9) 
with 1,2-bis(diphenylphosphino)benzene (dppbz): Preparation of 
[Os{κ2-C,C-(MeBzIm-C6H4)}(dppbz)(NCCH3)2]OTf (11). dppbz 
(125.5 mg, 0.27 mmol) was added to a green solution of compound 9 
(200.0 mg, 0.27 mmol) in dichloromethane (5 mL). The green solu-
tion was stirred overnight at room temperature and then concentrated 
to dryness. The addition of diethyl ether (3 mL) resulted in the precip-
itation of a pale green solid which was washed with further portions 
of diethyl ether (3 x 3 mL) and dried in vacuo. Yield: 290.0 mg (90 
%). Anal. Calcd. for C49H41F3N4O3OsP2S: C, 54.74; H, 3.84; N, 5.21; 
S, 2.98. Found: C, 54.49; H, 4.12; N, 5.07; S, 2.88. HRMS (electros-
pray, m/z) calcd for C48H41N4OsP2 [M]+: 927.2421; found: 927.2439. 
IR (cm-1): ν(C≡N) 2259 (m), ν(CF) 1261 (vs), ν(SO) 1221 (m), ν(SO) 
1147 (s), ν(SO) 1030 (vs). 1H NMR (300 MHz, CD2Cl2, 298 K): δ 
8.30-8.20 (m, 1H, CH), 8.00-7.90 (m, 1H, CH), 7.90-7.80 (s, 1H, 
CH), 7.60-7.20 (m, 27H, CH), 7.20-7.10 (m, 1H, CH), 6.80-6.70 (m, 
1H, CH), 3.80 (s, 3H, NCH3), 1.60 (s, 6H, 2 NCCH3). 13C{1H} + 
HMBC+ HSQC NMR (75 MHz, CD2Cl2, 298 K): δ 187.8 (dd, 2JC-P = 
90.2, 2JC-P = 4.4, NCN), 152.1 (d, 3JC-P = 2.5, Cq), 148.1 (dd, 2JC-P = 
70.9, 2JC-P = 5.8, Os-C), 148.0 (d, 1JC-P = 46.0, 2JC-P = 33.3, Cq), 145.1 
(d, 1JC-P = 47.5, 2JC-P = 33.3, Cq), 143.7 (d, 3JC-P = 6.8, CH), 137.0 (d, 
4JC-P = 3.2, Cq), 135.3 (dd, JC-P = 13.4, JC-P = 1.8, CH), 135.5-134.9 
(m, Cq), 134.6 (dd, JC-P = 12.9, JC-P = 2.0, CH), 133.8 (d, JC-P = 9.7, 
CH), 133.2 (d, JC-P = 10.3, CH), 132.3 (dd, 1JC-P = 43.9, 2JC-P = 2.3, 
Cq), 131.7 (dd, JC-P = 4.9, JC-P = 1.6, CH), 131.5 (dd, JC-P = 5.4, JC-P = 
1.4, CH), 130.6 (d, JC-P = 2.0, CH), 130.6 (d, JC-P = 1.8, CH), 129.5 (d, 
JC-P = 8.9, CH), 129.0 (d, JC-P = 9.4, CH), 125.0 (dd, 3JC-P = 5.0, 3JC-P 
= 1.3, CH), 124.5 (s, CH), 123.7 (s, CH), 123.6 (s, CH), 116.4 (s, 
NCCH3), 113.1 (d, JC-P = 1.8, CH), 112.6 (s, CH), 111.6 (s, CH), 36.6 
(d, 4JC-P = 3.6, NCH3), 3.9 (s, NCCH3). 31P{1H} NMR (121.49 MHz, 
CD2Cl2, 298 K):  32.3 (d, 2JP-P = 17), 23.8 (d, 2JP-P = 17). 19F{1H} 
NMR (282 MHz, CD2Cl2, 298 K): δ -80.7 (s). 
Reaction of [Os{κ2-C,C-(MeBzIm*-C6H4)}(NCCH3)4]OTf (10) 
with 1,2-bis(diphenylphosphino)benzene (dppbz): Preparation of 
[Os{κ2-C,C-(MeBzIm-C6H4)} (bppbz)(NCCH3)2]OTf (12). dppbz 
(302.2 mg, 0.677 mmol) was added to a green solution of compound 
10 (500.0 mg, 0.677 mmol) in dichloromethane (15 mL). The green 
solution was stirred overnight and then concentrated to dryness. The 
addition of diethyl ether (6 mL) resulted in the formation of a green 
oil which was stirred in a cold bath (195 K) and a pale green solid 
precipitated. The green solid was washed with further portions of 
diethyl ether (3x4 mL) and dried in vacuo. Yield: 568.5 mg (76 %). 
Anal. Calcd. for C51H45F3N4O3OsP2S: C, 55.53; H, 4.11; N, 5.08; S, 
2.91. Found: C, 55.50; H, 4.44; N, 4.86; S, 2.88. HRMS (electrospray, 
m/z) calcd for C50H45N4OsP2 [M]+: 955.2734; found: 955.2781. IR 
(cm-1): ν(C≡N) 2258 (w), ν(CF) 1260 (s), ν(SO) 1221 (m), ν(SO) 
1148 (s), ν(SO) 1029 (s). 1H NMR (300 MHz, CD2Cl2, 298 K): δ 7.99 
(s, 1H, CH), 8.00-7.90 (m, 1H, CH), 7.90-7.80 (m, 1H, CH), 7.50-
7.20 (m, 24H, CH), 7.22 (s, 1H, CH), 7.20-7.00 (m, 1H, CH), 6.80-
6.60 (m, 1H, CH), 3.70 (s, 3H, NCH3), 2.51 and 2.44 (both s, 3H 
each, CH3), 1.57 (s, 6H, 2 NCCH3). 13C{1H} + HMBC+ HSQC NMR 
(75 MHz, CD2Cl2, 298 K): δ 186.3 (dd, 2JC-P = 90.2, 2JC-P = 4.5, 
NCN), 152.3 (d, 3JC-P = 2.4, Cq), 148.1 (d, 1JC-P = 45.9, 2JC-P = 33.5, 
Cq), 148.0 (dd, 2JC-P = 70.9, 2JC-P = 5.9, Os-C), 145.2 (d, 1JC-P = 47.4, 
1JC-P = 33.4, Cq), 143.7 (d, 3JC-P = 6.8, CH), 135.6 (d, 4JC-P = 3.6, Cq), 
135.3 (dd, JC-P = 13.5, JC-P = 1.6, CH), 135.2 (dd, 1JC-P = 36.4, 2JC-P = 
2.4, Cq), 134.6 (dd, JC-P = 12.9, JC-P = 1.9, CH), 133.8 (d, JC-P = 9.8, 
CH), 133.2 (d, JC-P = 10.4, CH), 133.7 (s, Cq), 132.9 (s, Cq), 132.4 
(dd, 1JC-P = 43.7, 2JC-P = 2.3, Cq), 131.7 (dd, JC-P = 5.0, JC-P = 1.6, CH), 
131.6 (d, 4JC-P = 1.9, JC-P = 1.6, Cq), 131.5 (dd, JC-P = 5.6, JC-P = 1.9, 
CH), 130.6 (d, JC-P = 2.0, CH), 130.5 (d, JC-P= 1.8, CH), 129.4 (d, JC-P 
= 8.9, CH), 129.0 (d, JC-P = 9.3, CH), 124.8 (dd, 3JC-P = 5.0, 3JC-P = 
1.2, CH), 123.5 (s, CH), 116.3 (s, NCCH3), 113.2 (s, CH), 113.0 (d, 
JC-P = 2.2, CH), 111.9 (s, CH), 36.5 (d, 4JC-P = 3.7, NCH3), 20.8 and 
20.4 (both s, both CH3), 3.9 (s, NCCH3). 31P{1H} NMR (121.49 MHz, 
CD2Cl2, 298 K): δ 32.3 (d, 2JP-P = 17), 23.9 (d, 2JP-P = 17). 19F{1H} 
NMR (282 MHz, CD2Cl2, 298 K): δ -79.0 (s). 
Reaction of [Os{κ2-C,C-(MeBzIm-C6H4)}(dppbz)(NCCH3)2]OTf 
(11) with 1-phenyl-3-methyl-1-H-benzimidazolium Iodide 
([PhMeBzImH]I): Preparation of Os{κ2-C,C-(MeBzIm-
C6H4)}2(dppbz) (13). A solution of complex 11 (500 mg, 0.47 mmol), 
[PhMeBImH]I (157.7 mg, 0.47 mmol) and NEt3 (630 µL, 4.5 mmol) 
in dimethylformamide (10 mL) was stirred for three days at 110 ºC. 
The resulting yellowish suspension was concentrated in vacuo to 
dryness. The addition of toluene (40 mL) resulted in a brownish-
yellow suspension. The yellow solution was extracted and concentrat-
ed to ca~1 mL and cold methanol (8 mL) was added allowing to 
precipitate a yellow solid. The yellow solid was washed with further 
portions of methanol (2x3 mL) and dried in vacuo. Yield: 275.0 mg 
(56 %). Anal. Calcd. for C58H46N4P2Os: C, 66.27; H 4.41; N 5.33. 
Found: C 66.05; H 4.53; N 5.19. HRMS (electrospray, m/z) calcd for 
C58H46N4P2Os [M]+: 1052.2813; found: 1052.2818. 1H NMR (500 
MHz, CD2Cl2, 298 K): δ 8.01-8.00 (m, 1H, CH), 8.00-7.90 (m, 1H, 
CH), 7.90-7.80 (m, 1H, CH), 7.90-7.70 (m, 2H, CH), 7.80-7.50 (m, 
6H, CH), 7.30-7.10 (m, 11H, CH), 7.10-7.00 (m, 1H, CH), 7.00-6.90 
(m, 1H, CH), 6.90-6.80 (m, 1H, CH), 6.90-6.70 (m, 2H, CH), 6.80-
6.70 (m, 2H, CH), 6.70-6.60 (m, 1H, CH), 6.60-6.50 (m, 1H, CH), 
6.50-6.40 (m, 2H, CH), 6.40-6.20 (m, 5H, CH), 6.20-6.10 (m, 2H, 
CH), 3.35 (s, 3H, NCH3), 2.16 (s, 3H, NCH3). 13C{1H} + HMBC+ 
HSQC NMR (126 MHz, CD2Cl2, 298 K): δ 199.9 (br, NCN), 195.5 
(br, NCN), 158.2 (br, Os-C Ph), 152.3 (br, Cq), 151.2 (br, Cq), 148.4 
(br, Cq), 145.2 (br, Cq), 143.9 (br, Cq), 143.0 (s, CH), 142.5 (s, Cq), 
140.6 (s, CH), 138.2 (s, Cq), 137.4 (s, CH), 136.5 (d, JC-P = 8.6, CH), 
134.4 (m, Cq), 133.7 (s, CH), 133.6 (s, Cq), 133.4 (s, CH), 133.2 (s, 
Cq), 130.8, 130.3, 130.2, 129.9, 129.3, 128.7, 128.3, 127.8, 127.5, 
127.3, 126.4, 123.3 (all s, CH), 123.0 (br, Cq), 122.5, 121.9, 121.6, 
121.2, 120.7 (all s, CH), 120.2 (br, Cq), 111.7 (br, Cq), 111.5, 111.2, 
110.3, 109.5, 109.4 (all s, CH), 34.2 (s, CH3), 34.2-34.0 (m, CH3) 
(three CH aromatic signals are not observed, probably due to overlap-
ping). 31P{1H} NMR (121.48 MHz, DMF, 298 K): δ 30.0 (d, 2JP-P = 
5.0), 24.7 (d, 2JP-P = 5.0). 
Reaction of [Os{κ2-C,C-(MeBzIm*-
C6H4)}(dppbz)(NCCH3)2]OTf (12) with 1-phenyl-3-methyl-1H-
5,6-dimethylbenzimidazolium Iodide ([PhMeBzIm*H]I): Prepa-
ration of Os({κ2-C,C-(MeBzIm*-C6H4)}2(dppbz) (14). A solution of 
complex 12 (400 mg, 0.36 mmol), [PhMeBIm*H]I (132.0 mg, 0.36 
mmol) and NEt3 (500 μL, 3.6 mmol) in DMF (8 mL) was stirred for 
three days at 110 ºC. The resulting yellowish suspension was concen-
 trated in vacuo to dryness and purified by chromatography (silicagel 
230-400 mesh and diethyl ether as eluent) yielding 14 as a yellow 
solid. Yield: 85 mg (21%). Anal. Calcd. for C62H54N4OsP2: C, 67.25; 
H, 4.91; N, 5.06. Found: C, 67.58; H, 4.54; N, 4.86. HRMS (electros-
pray, m/z) calcd for C62H54N4OsP2 [M]+: 1108.3439; found: 
1108.3424. 1H NMR (500 MHz, CD2Cl2, 298 K): δ 8.10-8.00 (m, 1H, 
CH), 7.90-7.80 (m, 1H, CH), 7.80-7.70 (m, 4H, CH), 7.70-7.50 (m, 
4H, CH), 7.50 (s, 1H, CH), 7.30-7.10 (m, 7H, CH), 7.00-6.90 (m, 1H, 
CH), 6.90 (s, 1H, CH), 6.80-6.70 (m, 4H, CH), 6.50-6.40 (m, 5H, 
CH), 6.40-6.30 (m, 4H, CH), 6.30-6.20 (m, 1H, CH), 6.20-6.10 (m, 
2H, CH), 3.24 (s, 3H, NCH3), 2.40, 2.37, 2.33 and 2.30 (all s, 3H 
each, -CH3), 2.06 (s, 3H, NCH3). 13C{1H} + HMBC+ HSQC NMR 
(126 MHz, CD2Cl2, 298 K): δ 197.2 (br, NCN), 193.6 (br, NCN), 
157.4 (br, Os-C Ph), 152.0 (br, Os-C Ph), 148.4 (s, Cq), 145.2 (br, Cq), 
143.2 (br, CH), 143.0 (br, Cq), 142.8 (Cq), 142.4 (br, Cq), 140.3 (s, 
CH), 137.3 (s, CH), 137.7 (br, Cq) 136.8 (s, Cq), 136.4 (br, CH), 135.9 
(s, Cq), 133.6 (s, CH), 133.4 (s, CH), 132.1 (s, Cq), 131.7 (s, Cq), 
130.9 (s, Cq), 130.8 (s, CH), 130.3, (s, CH), 130.2 (s, Cq), 130.0 (s, 
CH), 129.7 (s, CH), 129.7 (s, Cq), 129.2, 128.7, 128.2, 127.6, 127.5, 
127.3, 126.3, 126.2, 122.9 (all s, CH), 122.5 (br, Cq), 120.5, 112.0, 
111.3, 111.2 (all s, CH), 111.0 (br, Cq), 110.1 (s, CH), 110.1 (s, CH), 
33. 9 (s, 2 CH3), 20.6, 20.6, 20.3 and 20.3 (all s, CH3) (some signals 
are not observed probably due to overlapping). 31P{1H} NMR (202 
MHz, DMF, 298 K): δ 29.6 (br), 26.0 (br). 
Structural Analysis of Complexes 2, 4, 6, 7, 11, and 13. X-ray 
data were collected for the complexes on a Bruker Smart APEX CCD 
(2, 4, 11 and 13) or APEX CCD DUO (6 and 7) diffractometers 
equipped with a normal focus, 2.4 kW sealed tube source (Mo radia-
tion, λ = 0.71073 Å) operating at 50 kV and 40 mA (4, 6 and 7) or 30 
mA (2, 11, and 13). Data were collected over the complete sphere. 
Each frame exposure time was 10 s (11 and 13), 20 s (2, 6 and 7) or 
30 s (4) (covering 0.3º in ω). Data were corrected for absorption by 
using a multiscan method applied with the SADABS program.42 The 
structures were solved by Patterson or direct methods and refined by 
full-matrix least squares on F2 with SHELXL97,43 including isotropic 
and subsequently anisotropic displacement parameters. The hydrogen 
atoms were observed in the least Fourier Maps or calculated, and 
refined freely or using a restricted riding model. The solvent mole-
cules of crystallization observed in the asymmetric unit in the differ-
ent structures were mostly observed disordered and refined with 
different moieties with restrained geometry, complementary occupan-
cy factors and isotropic displacement parameters. 
Crystal data for 2: C38H42BrN4OOsP, 3.5(CH2Cl2), MW 1169.08, 
yellow, irregular block (0.18 x 0.12 x 0.08 mm), triclinic, space group 
P-1, a: 11.8972(8) Å, b: 13.1287(8) Å, c: 16.5970(16) Å, α: 
102.1450(10)°, β: 94.2660(10)°, γ: 114.7860(10)°, V = 2261.9(3) Å3, 
Z = 2, Z’ = 1, Dcalc: 1.716 g cm-3, F(000): 1158, T = 100(2) K, μ 4.189 
mm-1. 27672 measured reflections (2θ: 3-58º, ω scans 0.3º), 10562 
unique (Rint = 0.0296); min./max. transm. factors 0.676/0.862. Final 
agreement factors were R1 = 0.0337 (9198 observed reflections, I > 
2θ(I)) and wR2 = 0.0882; data/restraints/parameters 10562/8/514; GoF 
= 0.881. Largest peak and hole 2.200 (close to the osmium atom) and 
-2.313 e/Å3. 
Crystal data for 4: C38H41N4OOsP, MW 790.92, yellow, irregular 
block (0.14 x 0.12 x 0.03), monoclinic, space group P21/n, a: 
13.485(2) Å, b: 15.011(3) Å, c: 16.212(3) Å, β: 100.785(2)°, V = 
3223.6(10) Å3, Z = 4, Z’ = 1, Dcalc: 1.630 g cm-3, F(000): 1584, T = 
100(2) K, μ 4.043 mm-1. 22489 measured reflections (2θ: 3-51o, ω 
scans 0.3o), 6061 unique (Rint = 0.0713); min./max. transm. factors 
0.631/0.862. Final agreement factors were R1 = 0.0509 (4295 ob-
served reflections, I > 2θ(I)) and wR2 = 0.1259; da-
ta/restraints/parameters 6061/50/413; GoF = 1.033. Largest peak and 
hole 3.495 (close to the osmium atom) and -1.786 e/Å3. 
Crystal data for 6: C54H42N4OsP2, 0.875(CH2Cl2), MW 1073.37, 
yellow, irregular block (0.14 x 0.05 x 0.04 mm), triclinic, space group 
P-1, a: 12.324(6) Å, b: 19.843(10) Å, c: 19.987(10) Å, α: 81.267(7)°, 
β: 75.348(6)°, γ: 88.797(7)°, V = 4673(4) Å3, Z = 4, Z’ = 2, Dcalc: 
1.526 g cm-3, F(000): 2147, T = 150(2) K, μ 2.940 mm-1. 71830 
measured reflections (2θ: 3-57o, ω scans 0.3º), 24119 unique (Rint = 
0.0357); min./max. transm. factors 0.682/0.862. Final agreement 
factors were R1 = 0.0352 (19735 observed reflections, I > 2θ(I)) and 
wR2 = 0.1011; data/restraints/parameters 24119/15/1146; GoF = 
1.048. Largest peak and hole 2.170 (close to the osmium atoms) and -
1.657 e/Å3. 
Crystal data for 7: C58H44N4OsP2, 3/2(CH2Cl2), MW 1176.50, yel-
low, irregular block (0.15 x 0.12 x 0.07 mm), monoclinic, space group 
C2, a: 20.470(3) Å, b: 19.715(3) Å, c: 24.976(3) Å, β: 104.265(2)°, V 
= 9768(2) Å3, Z = 8, Z’ = 2, Dcalc: 1.600 g cm-3, F(000): 4712, T = 
100(2) K, μ 2.887 mm-1. 66769 measured reflections (2θ: 3-58o, ω 
scans 0.3o), 19215 unique (Rint = 0.0572); min./max. transm. factors 
0.634/0.862. Final agreement factors were R1 = 0.0469 (17114 ob-
served reflections, I > 2θ(I)) and wR2 = 0.1196; Flack parameter 
0.014(6); data/restraints/parameters 19215/7/1245; GoF = 1.041. 
Largest peak and hole 2.656 (close to the osmium atoms) and -1.646 
e/Å3. 
Crystal data for 11: C48H41N4OsP2, CF3O3S, 0.5(CH2Cl2), 
0.5(C2H3N), MW 1138.05, green, irregular block (0.14 x 0.08 x 0.04 
mm), monoclinic, space group P21/c, a: 13.5713(14) Å, b: 19.295(2) 
Å, c: 18.4609(19) Å, β: 108.6970(10)°, V = 4579.1(8) Å3, Z = 4, Z’ = 
1, Dcalc: 1.651 g cm-3, F(000): 2272, T = 100(2) K, μ 3.020 mm-1. 
55736 measured reflections (2θ: 3-51º, ω scans 0.3º), 11059 unique 
(Rint = 0.0690); min./max. transm. factors 0.720/0.862. Final agree-
ment factors were R1 = 0.0400 (8625 observed reflections, I > 2θ(I)) 
and wR2 = 0.0793; data/restraints/parameters 11059/6/602; GoF = 
1.03. Largest peak and hole 1.329 (close to the osmium atom) and -
1.278 e/ Å3. 
Crystal data for 13: C58H46N4OsP2, 4(C6H6), MW 1363.56, yellow, 
irregular block (0.26 x 0.09 x 0.09 mm), triclinic, space group P-1, a: 
12.5444(9) Å, b: 14.9861(11) Å, c: 18.2590(14) Å, α: 72.4820(10)°, 
β: 83.0130(10)°, γ: 78.5460(10)°, V = 3201.1(4) Å3, Z = 2, Z’ = 1, 
Dcalc: 1.415 g cm-3, F(000): 1392, T = 100(2) K, μ 2.092 mm-1. 25024 
measured reflections (2θ: 3-58º, ω scans 0.3o), 14260 unique (Rint = 
0.0400); min./max. transm. factors 0.676/0.862. Final agreement 
factors were R1 = 0.0440 (12115 observed reflections, I > 2θ(I)) and 
wR2 = 0.0768; data/restraints/parameters 14260/0/804; GoF = 1.047. 
Largest peak and hole 0.887 (close to the osmium atom) and -1.710 e/ 
Å3. 
Computational details. All calculations were performed at the 
DFT level using the B3LYP functional44 supplemented with the 
Grimme’s dispersion correction D345 as implemented in Gaussi-
an09.46 The Os atom was described by means of an effective core 
potential SDD for the inner electron47 and its associated double-ζ 
basis set for the outer ones, complemented with a set of f-polarization 
functions.48 The 6-31G** basis set was used for the H, C, N and P 
atoms.49 All minima were verified to have no negative frequencies. 
All geometries were fully optimized in THF (ε = 7.4257) solvent 
using the continuum SMD model.50 For both 7 and 13 we performed 
TD-DFT calculations at the same level of theory calculating the 
lowest 50 singlet-singlet excitations at the ground state S0 and the 
lowest 5 singlet-singlet and 5 singlet-triplet excitations at the lowest 
excited triplet T1 optimized geometries. It has to be noticed that the 
singlet-triplet excitations are set to zero due to the neglect of spin-
orbit coupling in the TDDFT calculations as implemented in G09. 
The UV/vis absorption spectra were obtained by using the GaussSum 
3 software.51 
Supporting Information 
UV/Vis, normalized emission and excitation spectra for 7, 13, and 
14; molecular frontier orbitals for complexes 7 and 13, calculated 
UV spectra of complexes 7 and 13 (50 highest transitions), 1H 
NMR spectra of 3a and of partially deuterated 3a, and a CIF file 
giving positional and displacement parameters, crystallographic 
data, and bond lengths and angles of 2, 4, 6, 7, 11 and 13. The 
supplemental file Cartesian_coord.xyz contains the computed 
Cartesian coordinates of computed 7 and 13. The file may be 
opened as a text file to read the coordinates, or opened directly by 
a molecular modeling program such as Mercury for visualization. 
This material is available free of charge via the Internet at 
http://pubs.acs.org. 
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